Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents

被引：66

作者：

Carta, A

Sanna, P

Gherardini, L

Usai, D

Zanetti, S

机构：

[1] Dipartimento Farm Chim Tossicol, I-07100 Sassari, Italy

[2] Dipartimento Sci Biomed, I-07100 Sassari, Italy

来源：

FARMACO | 2001年 / 56卷 / 12期

关键词：

pyrido[2,3-g]quinoxalinones; antibacterial; anticandida; anticancer activities;

D O I：

10.1016/S0014-827X(01)01161-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A series of twelve novel pyrido[2,3-g]quinoxalinones (3-14), variously substituted at the C-3 position, was synthesized, structurally determined and submitted to a preliminary in vitro evaluation for antibacterial, anticandida and anticancer activities. Results of the antimicrobial screening showed that all compounds, with the exception of 6, 11 and 12, exhibited interesting activity against all strains tested; while compound 10 was found to have encouraging in vitro anticancer activity at a concentration of 10(-4) M. (C) 2001 Elsevier Science S.A. All rights reserved.

引用

页码：933 / 938

页数：6

共 14 条

[1]

Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1

[2]

CARTA A, 2000, NOVEL FUNCTIONALIZED

[3]

DENNY WA, 1995, CANC CHEMOTHERAPEUTI, P218

[4]

GIORGIRENAULT S, 1985, EUR J MED CHEM, V20, P144

[5] BIOACTIVATION AS A MODEL FOR DRUG DESIGN BIOREDUCTIVE ALKYLATION [J].

MOORE, HW .

SCIENCE, 1977, 197 (4303) :527-532

[6]

*NAT COMM CLIN LAB, 1990, M7A2 NAT COMM CLIN L

[7]

*NAT COMM CLIN LAB, 1992, M26T NAT COMM CLIN L

[8] Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity [J].

Sanna, P ;

Carta, A ;

Loriga, M ;

Zanetti, S ;

Sechi, L .

FARMACO, 1998, 53 (07) :455-461

[9] Synthesis of two novel tricyclic rings:: Triazolo[4,5-g]quinolines and pyrido[2,3-g]quinoxalines derived from 6,7-diaminoquinolines [J].

Sanna, P ;

Carta, A ;

Paglietti, G .

HETEROCYCLES, 2000, 53 (02) :423-+

[10] Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2 [J].

Sanna, P ;

Carta, A ;

Loriga, M ;

Zanetti, S ;

Sechi, L .

FARMACO, 1999, 54 (03) :161-168

← 1 2 →